Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors(legacy) | 138 |
| CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors(legacy) | 78 |
Total Visits per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors | 0 | 4 | 3 | 5 | 0 | 5 | 0 |
File Downloads
| Views | |
|---|---|
| hdl_101845.pdf(legacy) | 118 |
| hdl_101845.pdf | 98 |
Top Country Views
| Views | |
|---|---|
| Australia | 76 |
| United States | 57 |
| China | 19 |
| Vietnam | 11 |
| Germany | 10 |
| France | 10 |
| Netherlands | 8 |
| United Kingdom | 4 |
| Finland | 2 |
| India | 2 |
Top City Views
| Views | |
|---|---|
| Kaleen | 48 |
| Ashburn | 26 |
| Hanoi | 11 |
| Rotterdam | 8 |
| Fairfield | 6 |
| Guangzhou | 3 |
| Nürnberg | 3 |
| Helsinki | 2 |
| London | 2 |
| Nanjing | 2 |